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Abstract
Background and purpose of the study: Pharmacies as direct providers of medicine and pharmaceutical services
to patients have an important role in the health status of a society. The assessment of their financial situations by
healthcare policy makers is necessary to prevent any negative effects on population’s health. In this study we aim
to analyze the financial status of pharmacies in Tehran, Iran.
Methods: This study is a cross-sectional study based on a survey. Two-hundred and eighty-eight private
community daytime pharmacies in Tehran were selected by random sampling. We used two questionnaires to
collect data regarding cost, expense and income factors of private pharmacies and the significance of each of them
from these selected pharmacies. The data was collected in 2011 from Tehran pharmacies. Profitability of pharmacies
in Tehran, Iran was calculated in its current situation and then estimated for three defined scenarios: 1. The
dispensing fee is omitted (ceteris paribus), 2. Pharmacies are prohibited from selling hygienic & cosmetic products
(ceteris paribus), 3. Scenarios 1 and 2 together (ceteris paribus). These data were analyzed by using SPSS and
descriptive-analytic statistics.
Results: About 68% of interviewees responded to our questionnaires. Our analysis indicated that the average
annual costs (and expenses), income and profits of pharmacies are 73,181; 106,301; and 33,120 United States Dollar
(USD), respectively. The analysis indicated that omission of dispensing fee (scenario 1) and prohibition of
pharmacies from selling hygienic & cosmetic products (scenario 2) would decrease income of pharmacies to 18438
and 14034 USD/year, respectively. According to respondents, the cost (or expense) of properties and buildings,
energy, taxes, delays in reimbursement by insurance companies, and renting the place of pharmacy could be
considered as cost factors and prescription medicines, OTC medicines, dispensing fees, hygienic & cosmetic
products, and long-term payment to pharmaceutical distribution companies as income factors, which have
significant effects on a pharmacy’s economy.
Major conclusions: According to the results of this study, regarding the pharmacies’ cost (and expenses) and
incomes, the omission of dispensing fees for prescriptions has considerable negative effects on the profitability of
pharmacies and likely on society’s health.
Keywords: Pharmacy, Income, Cost and expense, Profitability, Dispensing fee, Iran
* Correspondence: Kebriaee@tums.ac.ir
1Department of Pharmacoeconomics and Pharmaceutical administration,
Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Full list of author information is available at the end of the article
© 2012 Keshavarz et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Keshavarz et al. DARU Journal of Pharmaceutical Sciences 2012, 20:62
http://www.darujps.com/content/20/1/62Introduction
Different countries use a variety of methods to organize
their health systems. In these systems, the position of
the pharmaceuticals is especially critical [1]. Pharmacies
as direct providers of medicines and pharmaceutical ser-
vices as well as potential centers for research in health
services are one of the most important components of a
health system [2]. Existence of private pharmacies in dis-
tribution network of medicines could provide good ac-
cessibility for medicines within the country [3,4].
Regarding to Iranian National Drug Policy (NDP) Private
pharmacies belong to pharmacists who are allowed
to establish their pharmacy under district regulation
and legislation of Ministry of Health (MOH). They
are responsible to provide medicines of National Drug
List (NDL) for all patients and provide appropriated in-
formation according use of medicines [4]. Chain phar-
macies and investment in multiple pharmacies are not
allowed in Iran.
Nowadays, a wide range of services are provided by
pharmacists, the results of which are an improvement in
the overall health of a society. Studies have shown that
the services provided by practical pharmacists create
considerable improvement in health outcomes of society
[5]. In addition, numerous studies show the role of phar-
macists in diagnosing medical errors, medical interac-
tions, and inappropriate prescribing [6-10]. Therefore,
pharmacists have an important role in choosing the
most appropriate, optimal and effective method of treat-
ment [11].
In recent years, there has been controversy between
policy makers and pharmacies regarding the omission of
dispensing fees in Iran. Dispensing fee is a payment by
patient to pharmacist after receiving prescription medi-
cines to compensate pharmacy services including con-
sultation, education on medicine usage and etc. The
opposing sides have two different approaches. To solve
the high amount of out-of-pocket payments by patients
in Iran, some policymakers’ approach is to omit the dis-
pensing fee, given that it is not covered by most insur-
ance companies. This approach is supported by some
views in society regarding the extraordinary profit of
pharmacies. In the second approach, pharmacists believe
that the present situation of implemented policies in pri-
cing areas, public pharmacy monopolies, internal infla-
tion, etc. have caused many hardships, and the omission
of the dispensing fee would lead to bankruptcy. Dispens-
ing fee in Iran has two level: for prescriptions that their
price are more than 0.8 USD it is about 0.75 USD and
for prescription price under 0.8 USD it is 0.4 USD.
Currently in Iran, community pharmacies are divided
into two types: public and private. According to the latest
statistics from the Iranian Food and Drug Organization
(2011), there are about 8,400 active pharmacies in Iran.
Of these, 88% are privately owned and the rest are
affiliated with public organizations or institutions. Al-
though there are very few public pharmacies in Iran,
they still have a large market share for many reasons,
such as a monopoly in providing scarce and expensive
medicines [12]. The pharmaceutical market has been
extended by growth in GDP and health budgets but
this extension had a small effect on health indicators
[13]. Paying attention to the incentives for health ser-
vice providers including pharmacies could improve
health indicators.
Regarding the important role of pharmacies and their
potential effects on the health of society, especially in
low- and middle-income countries [14-17], all financial
and non-financial incentives and disincentives regarding
their role have to be monitored, and before any deci-
sions are made the impacts of that policy on pharmacies’
business has to be exactly analyzed.
In this study, we aim to analyze the financial situation
and factors that affect the financial flow of private phar-
macies and also attitudes of pharmacy owners regarding
these factors to render a more clear understanding of
the business aspects of pharmacies for policy makers.
Method
This research is a cross-sectional study based on a sur-
vey, which was conducted in 2011 in two steps. In the
first step, we tried to calculate the average profitability
of private community pharmacies in Tehran based on
data collected through questionnaires filled out by phar-
macy owners. In this step, the profitability of a pharmacy
was recalculated in three predefined scenarios to predict
the situation of pharmacies after implementing such
policies.
1. The dispensing fee is omitted (ceteris paribus)
2. Pharmacies are prohibited from selling hygienic &
cosmetic products (ceteris paribus), [approximately
all pharmacies in Iran provide hygienic & cosmetic
products].
3. Scenarios 1 and 2 together (ceteris paribus)
In the second step, we aimed to achieve a general
knowledge about the attitude of respondents toward
the factors affecting the cost, expense and income
components of pharmacies. The results of this step and
the previous step were combined to suggest solutions
for the current problems that face pharmacies and
patients.
Data collection measures
To evaluate the cost (and expense) and income informa-
tion of pharmacies, the factors that affect the costs,
expenses and income, and the importance of each factor
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naires were designed after a comprehensive literature re-
view. The first was an open-ended and self-administered
questionnaire in order to collect data from the pharmacy
owners about costs, expenses and incomes of pharma-
cies. The second was a Likert-scaled questionnaire to
collect information about the attitude of pharmacy man-
agers toward the factors that affect the financial flow of
a pharmacy. In both steps the data collection was
designed to be through direct interviews. The validity
and reliability of each questionnaire were checked by
combination of expert opinion, pilot data collection
from 10 pharmacies based on likert scale, and test-retest
methods (r=0.83).
The respondents were free to refuse to answer these
questionnaires, and they were assured before the inter-
view that their identity would remain private.
Sampling
Our population of interest included all of the private
community pharmacies in Tehran (capital of Iran).
According to Iranian Pharmacists’ Association statistics
(2011), there are 1,176 private pharmacies in Tehran, in-
cluding 1,115 daytime pharmacies and 61 pharmacies
open 24/7. As a sample, 228 pharmacies were selected
by a random sampling method. Daytime pharmacies
were only included in our study. For random selection
we used random number table after assigning to all day-
time pharmacies a number.
The respondents to the questionnaires were the phar-
macy managers, whether they were pharmacists or not.
Analysis
The analysis was conducted based on a typical daytime
pharmacy, which was extracted from questionnaires.
We used nonparametric techniques, including chi-
square test by SPSS 18 software to analyze the data of
study. To exchange IR Rial to US Dollar the official ex-
change rate declared by central bank (12260 IR Rials)
was used.
The method of study was reviewed and approved by
Institutional Review Board (IRB) of Tehran University of
Medical Sciences (code of project: 900410216512).
Results
About 68% of interviewees responded to our question-
naires. The results of our analysis is presented below.
Part 1: Profitability of pharmacies
In Table 1, the general information regarding the num-
ber of pharmacies, margins and other needed data are
collected. Knowing these data help Tables 2 and 3 to be
better understood.
In Table 2, all the detailed information about the cost
(and expense) components of pharmacies are presented.
It shows that an average cost and expense of a daytime
pharmacy is 73,181 USD/year. Of this, 52% of expenses
relate to manpower, 26.8% relate to renting the phar-
macy building, and the remainder (21.2%) relate to other
expenses.
In Table 3, all income components of a typical phar-
macy are presented. The table shows that an average an-
nual income of a pharmacy equals 106,301 USD. This
income relates to prescription medicines (26.1%), over-
the-counter (OTC) drugs (17.5%), hygienic & cosmetic
products and orthopedics (18%), and dispensing fees
(13.8%). The results of Tables 2 and 3 show that the
average profit of a pharmacy equals 33,120 USD annu-
ally and 2,760 USD monthly. This monthly amount var-
ies from 1631.3 (Min) to 4894 (Max).
Scenario 1. The dispensing fee is omitted (ceteris paribus)
The results of the tables show that if the dispensing fee
is omitted, the average pharmacy income would be
decreased to 91,619 USD/year. If we deduct the costs
and expenses of pharmacy from this amount, the net in-
come of a pharmacy equals 18,438 USD in a year and
1,536.5 USD in a month (44% reduction).
Scenario 2. Pharmacies are prohibited from selling hygienic
& cosmetic products (ceteris paribus)
If the dispensing fee exists but the sale of hygienic &
cosmetic products is omitted, the pharmacy income
would be decreased to 87,215 USD/year. If we deduct
costs and expenses of pharmacy from this amount, the
net income of a pharmacy equals 14,034 USD per year
and 1,169.5 USD per month (58% reduction).
Scenario 3. Scenarios 1 and 2 together (ceteris paribus)
If both the dispensing fees and hygienic & cosmetic pro-
ducts are omitted and only the income of medicine sales
is calculated, then the pharmacy would generate an in-
come of 72533 USD, resulting in a net income of 648
USD and 54 USD lost annually and monthly, respect-
ively (98% reduction).
Table 1 General information about Iran pharmaceutical
market
12
Total number of pharmacies 8393
a
profit margin of selling domestic drugs (2011) 20%
profit margin of selling imported drugs (2011) 10-15%
The average profit gained from
distribution companies discount
3%
percentage of expired drugs in pharmacies 1%
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components of pharmacy business
In this part, the results of responders’ attitude toward
the significance of effective factors on a pharmacy’s eco-
nomic improvement are shown.
1. Factors affecting pharmacy costs: To answer this
question, two fixed factors and nine variable factors
were defined. In Table 4, the results of the statistical
analysis are presented to answer this question.
As Table 4 shows, according to respondents’ views,
the most significant factors affecting a pharmacy’s
costs and expenses are the properties and building
(as fixed costs); the manpower, consumed energy,
tax, and delays in reimbursement by insurance
companies to pharmacies (most of insurance
organization reimburse pharmacies after several
months from providing medicines to patient); and
renting the pharmacy location. However, the
consumed materials, insurance deductions, drug
expiration, and entering prescription data into a
computer program (some pharmacies doesn’t have
in-time prescription data entering in system and have
to pay for that) do not have a significant effect on
pharmacy costs and expenses.
2. Factors affecting pharmacies’ income: To answer this
question, seven factors are defined. In Table 5,
statistical analysis results are presented to answer this
question.
As the results in Table 5 show, according to
responders’ views, the income earned from the sale
of prescription medicines, OTC medicines,
dispensing fees, hygienic & cosmetic products and
long-term payment of purchasing from distribution
Table 2 The cost and expense components of pharmacies in 2011
Cost and Expense items Amount
(USD)
Min & Max
(USD)
Details (according to questionnaire
information and experts attitude
Fixed The average of depreciation
expense of properties
b
1697 (821 and 2049) The average, Min and Max properties
price is obtained from questionnaire
information and market price
Variable The average manpower expense 38203 (31593 and 44814) The average is based on four personnel:
pharmacist, pharmacy technician, cashier,
hygienic salesman. Max:
5 and Min: 3 personnel are included
The average expense of
renting pharmacy location
19576 (9788 and 48940) The average of monthly renting expense
is 1631 USD (Max: 4078 USD and
Min: 816 USD)
The average expense of
consumed energy (electricity,
gas, water, telephone)
1958 (1468 and 2936) The average of monthly consumed energy
expense is 163 USD (Max: 245 USD and
Min: 122 USD)
The average expense of
consumables
1468 (979 and 1958) The averageexpense of monthly consumablesis
122 USD/year (Max: 163 and Min: 82 USD/year)
Annual tax expense 2447 (1631 and 3263) The average expense of yearly tax is
2447 USD/year (Max: 3263 USD/year
and Min: 1631 USD/year)
The average of imposed
expenses and costs during
activities (insurance deductions,
drug expiration, drug waste)
1958 (979 and 2936) The average expense of monthly
imposed is 163 USD/year
(Max: 245 USD/year and Min: 82 USD/year)
The average expenses of delays
in insurance companies
reimbursements
3467 (2600 and 4333) It is calculated based on %17 bank
profits. The average delay is
considered as 4 months
(Max: 5 months and Min: 3 months)
The average expense of
entering prescription data
on computer
1918 (343 and 3837 ) To register each prescription
.07 USD/year and 24.5 days in a
month is calculated. The average
100 prescriptions in a day are included
(Max 200 and Min 70 prescriptions
The average of other expenses
(advertisement, repair and
maintenance, internet,
personnel food, software
updates, transportation)
489 (294 and 979) the average is 408 USD/year
(Max: 979 USD/year and Min 82 USD/year)
The average total expense
of a pharmacy (2011)
73181
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income (p < 0.01), but other factors, such as the
income gained from pharmaceutical company
discounts and increases in drug prices, do not have
significant effects on pharmacies’ income (p > 0.05).
3. Solutions to improve pharmacies’ economy: To
answer this question, nine factors were defined. In
Table 6, the statistical analysis results are presented
to answer this question.
As Table 6 shows, according to responders’ views, tax
exemption, selling of hygienic & cosmetic products,
scarce and exclusive medicine (in Iran some
medicines like opioids, and very expensive anti
cancers and etc. are only available in public
pharmacies), medicine margin, insurance coverage of
medicines, quick insurance reimbursement,
dispensing fees, and financial support (p < 0.01) are
the most effective methods of pharmacies’ financial
improvement. However, the increase in share of
insurance from drug costs is not effective on
pharmacies’ financial improvement (p > 0.05), from
the pharmacy owners’ points of view.
Discussion
According to the results, our study showed that the
average profit of a typical pharmacy in Tehran is 2,760
Table 4 the results of statistical analysis (the attitude of pharmacists about the factors relating the expenses of
pharmacy)
Variables Responders attitude Degree of
freedom (df)
chi square
(X
2)
Significance
Strongly
agree
agree neutral disagree Strongly
disagree
Fixed properties 63 164 38 12 11 4 277.521 0
building 113 130 23 14 8 4 240.785 0
Variable manpower 156 85 24 14 9 4 274.743 0
consumables 45 66 62 55 60 4 4.535 0.338
consumed energy 61 78 61 41 47 4 14.361 0.006
renting location 65 74 62 41 46 4 13.076 0.011
tax 38 93 60 49 48 4 31.41 0
insurance deductions 50 71 62 50 55 4 5.576 0.233
drug expiration 47 75 62 49 55 4 8.944 0.063
delay in reimbursement 70 83 58 42 35 4 26.965 0
description registration 44 60 72 60 52 4 7.556 0.109
Table 3 The income components of pharmacies in 2011
Income items Amount Max & Min Details (according to questionnaire
information and experts attitude) (USD/year) (USD/year)
The average net income gained
from selling prescription medicines
27732 (11093 and 55465) The net income is calculated
based on averagely 17% margin
The average net income gained
from selling OTC drugs
18597 (14682 and 36705) The net income is calculated
based on averagely 19% margin
The average net income gained
from selling hygienic & cosmetic products
19086 (14682 and 36705) The net income is calculated
based on averagely 18% averagely margin
The average net income gained
from dispensing fees
14682 (12235 and 23246) It is calculated based on
averagely 49 USD/year
The average net income gained
from discounts and distribution companies prizes
13051 (979 and 19576) It is calculated based on 5% discounts
The average net income gained
from purchases with long-term payments
5200 (1733 and 8666) It is calculated based on average
reimbursement of 3 months
(Max: 5months and Min: 1 month).
Also bank profit in 2011 supposed to be 17%
The average net income gained
from increase of drug prices
7953 (3670 and 12235) It is calculated based on the
average stock of 122349 USD/year
and 3%-10% increase in prices
The average total income of a
pharmacy (2011)
106301
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showed that some factors—including tax exemptions,
sale of hygienic & cosmetic products, coverage of medi-
cines by insurance companies, quick insurance reim-
bursement, dispensing fees, and appropriate financial
incentives—have a greater effect on offering pharma-
ceutical services and also pharmacy income.
This is the first comprehensive study about business-
related issues of pharmacies in Iran, which encompasses
most of the expense (and cost) and income components
of pharmacies as well as the effective factors on the prof-
itability of pharmacies from pharmacists’ and pharmacy
owners’ points of view. Similar studies from other coun-
tries were also not found.
Our research seems to be consistent with Pourheidari’s
study (2010) in which the pharmacy income was only
slightly more than its costs and expenses [18]. This re-
sult is also in conflict with some policymakers’ views
about the extraordinary profitability of pharmacies. It
also should be mentioned that to establish a pharmacy
and enter the market, a large amount of investment is
needed in advance (an average investment to establish a
pharmacy in Tehran is estimated to be 264698 USD). In
this study, however, only the active pharmacies were
taken into account in order to calculate their fixed and
variable costs and expenses, so we neglected establish-
ment costs. On the other hand, regarding the social re-
sponsibility and important role of pharmacies, the
difference between cost and income does not seem to
be appropriate because this calculated profit encom-
passes some nonprofessional service provision, including
sale of hygienic & cosmetic products. If pharmacies
were prohibited from providing such services, their prof-
itability would likely decrease, as the scenarios showed.
From this aspect, our study is similar to a study by
Mohammadzade (2010), indicated that pharmacies are
not profitable but even disadvantageous if they only pro-
vide medicines [19].
The evidence showed that pharmacy margins have an
important role in whether or not pharmacists convince
patients to use brand or generic medicines [20]. There-
fore, it must be mentioned by policymakers that decreas-
ing pharmacies’ profitability by cost containment or any
other strategy may lead the pharmacies to compensate
their profit through other ways, either legal or illegal, in-
cluding selling non-OTC medicines without prescription,
Table 5 the results of statistical analysis (attitude of pharmacists about the factors relating the income of pharmacies)
Variables Responders attitude Degree of
freedom (df)
chi square
(X
2)
Significance
(sig) Strongly
agree
agree neutral disagree Strongly
disagree
Description 173 70 22 13 10 4 329.743 0
OTC 82 162 28 9 7 4 33.229 0
dispensing fee 171 85 19 7 6 4 352.833 0
cosmetic hygienic products 103 142 21 14 8 4 258.424 0
company discounts 40 56 72 62 58 4 9.361 0.053
increase in drug prices 44 65 67 53 59 4 6.097 0.192
A 78 162 32 9 7 4 293.285 0
Table 6 the results of statistical analysis (the ways to improve business of pharmacy)
Variables Responders attitude Degree of
freedom (df)
chi square
(X
2)
Significance
(sig) Strongly
agree
agree neutral disagree Strongly
disagree
tax exemption 82 169 21 9 7 4 334.5 0
exclusive selling of some
cosmetic-hygienic products
64 169 30 13 12 4 33.021 0
elimination of monopolies
regarding providing medicines
93 156 21 11 7 4 295.264 0
drug margin increase 88 161 23 9 7 4 307.903 0
coverage of drug items 64 162 37 13 12 4 267.938 0
increasing the share of
insurance companies
40 56 72 62 58 4 9.361 .053
quick insurance reimbursements 80 164 27 12 5 4 305.646 0
dispensing fee 68 165 32 13 10 4 287.382 0
loans 93 149 28 10 8 4 264.049 0
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set those policies and sometimes threaten the society’s
health. A study regarding European Union (EU) coun-
tries’ pharmaceutical policies after the economic crisis
indicated that pharmacies, as one of the important stake-
holders in the healthcare system, were taken into consid-
eration in designing such cost-controlling policies [21].
We must note that our results were concluded regardless
of the appropriateness or weaknesses of the current
implemented policies, including dispensing fees, and they
must be evaluated in term of equity, efficiency, patient
satisfaction, and other issues in further studies.
Another point is about the effect of insurance coverage
level on pharmacies’ business. However, the coverage of
medicines by insurance, probably because of its effect of
increasing demand, was considered as an effective factor
on profitability of pharmacies from the pharmacy own-
ers’ point of view, but the increase in share of insurance
from pharmaceutical costs was not identified by them as
a significantly effective factor. This could be justified by
reasons including the irrational delays by insurance in
reimbursement to pharmacies. The studies also showed
that the profitability of prescription medicines has
decreased [22]; a primary reason could be the increasing
contribution of insurance on prescription price [11, 22].
Limitations
In this study we were faced with limited access to data,
given that most pharmacists and pharmacy owners were
reluctant to disclose their business-related data. The ex-
pense (and cost) and income data were collected in a
self-reported way, and the validity of their claims could
not be evaluated.
Conclusion
It can be concluded that there is a gap in the current fi-
nancial situation of pharmacies in Tehran of optimal sta-
tus in terms of profitability. This situation would be
worse, however, if the considered scenarios (omission of
dispensing fees and sales of hygienic & cosmetic pro-
ducts) are implemented.
Endnotes
a According to Food and Drug Organization about
95% of them have private ownership and only 5% are
public
b The Straight-line depreciation method was used to
compute depreciation of assets in pharmacies
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